Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 27, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Algorithm development for diagnostic biomarker assays.

Rauf Izmailov1, Paul C Guest, Sabine Bahn

  • 1Rules-Based Medicine, Inc., Austin, Texas, USA.

International Review of Neurobiology
|November 5, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From case-control averages to validated subgroups: Interpreting inflammatory and neuroaxonal-injury biomarkers in schizophrenia and major depression.

Brain, behavior, & immunity - health·2026
Same author

Investigating Factors Associated With Spontaneous Remission in Individuals With Alcohol Use Disorder-Results From a Multi-Site Longitudinal Cohort Study.

Addiction biology·2026
Same author

Resting-State Brain Age Predicts Cognitive and Sensorimotor Deficits in Schizophrenia Spectrum Disorders: A Validation & Longitudinal Study.

Research square·2026
Same author

dsLassoCov: a federated Lasso approach incorporating covariate control.

Scientific reports·2026
Same author

Multimodal microglial and kynurenine pathway alterations across the affective-psychosis spectrum: a systematic review of patterns, heterogeneity, and dimensional implications.

Molecular psychiatry·2026
Same author

A multi-task learning approach combining regression and classification tasks for joint feature selection.

Scientific reports·2026
Same journal

Glutamate-Glutamine metabolism and transport, implications in Parkinson's disease.

International review of neurobiology·2026
Same journal

Redox bioenergetics of neuronal senescence in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Neurovascular coupling and energy substrate delivery in Alzheimer's disease.

International review of neurobiology·2026
Same journal

From metals to mitochondria: Linking trace elements to energy crisis in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Invisible threats of microplastics induced toxicity: Oxidative and inflammatory pathways in the CNS and retina.

International review of neurobiology·2026
Same journal

Starved synapses: Gut microbiome dysbiosis and its role in Alzheimer's glucose impairment.

International review of neurobiology·2026
See all related articles

Researchers developed a novel serum test to aid in schizophrenia diagnosis. This blood test accurately identifies schizophrenia patients with high sensitivity and specificity, offering a new diagnostic tool.

Area of Science:

  • Biomarkers
  • Psychiatric Diagnostics
  • Immunology

Background:

  • Schizophrenia diagnosis relies on clinical symptoms, lacking objective biomarkers.
  • Need for reliable, objective diagnostic tools in psychiatry.

Purpose of the Study:

  • To develop and validate a serum-based biomarker test for schizophrenia diagnosis.
  • To identify a robust panel of immunoassays for schizophrenia detection.

Main Methods:

  • Development of a multiplex immunoassay panel (initially 51, refined to 40 assays).
  • Utilized a linear support vector machine for diagnostic algorithm development.
  • Cross-validation and recalibration procedures for assay robustness and lot-to-lot consistency.

Main Results:

Related Experiment Videos

Last Updated: May 27, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

  • Achieved high sensitivity and specificity in identifying schizophrenia patients versus controls.
  • Receiver operating characteristic (ROC) area under the curve (AUC) of 88% for the diagnostic rule.
  • Demonstrated consistent performance across reagent lot changes.

Conclusions:

  • A validated serum biomarker panel can aid in the objective diagnosis of schizophrenia.
  • The developed test offers a reproducible, accurate, and robust method for clinical use.
  • This approach enhances diagnostic capabilities in psychiatric care.